Abbott Laboratories (ABT) Research & Development (2009 - 2026)

Abbott Laboratories (ABT) has 18 years of Research & Development data on file, last reported at $767.0 million in Q1 2026.

• For the quarter ending Q1 2026, Research & Development rose 7.12% year-over-year to $767.0 million; the trailing twelve-month figure through Mar 2026 stood at $3.0 billion (up 4.07% YoY), and the FY2025 full-year result was $2.9 billion, up 3.45% from the prior year.
• Research & Development climbed to $767.0 million in Q1 2026, from $735.0 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $782.0 million in Q3 2022 to a low of $654.0 million in Q1 2023.
• A 5-year average of $716.6 million and a median of $715.0 million in 2023 frame the typical range for Research & Development.
• Across the five-year window, Research & Development grew 16.37% in 2022 and dropped 14.07% in 2023, its largest moves.
• Tracing ABT's Research & Development over 5 years: stood at $725.0 million in 2022, then fell by 3.45% to $700.0 million in 2023, then increased by 7.0% to $749.0 million in 2024, then fell by 1.87% to $735.0 million in 2025, then gained by 4.35% to $767.0 million in 2026.
• Business Quant data shows ABT's Research & Development at $767.0 million in Q1 2026, $735.0 million in Q4 2025, and $766.0 million in Q3 2025.